What is xgeva for?

What is Xgeva used for?

Xgeva, also known as denosumab, is a medication used to treat various conditions related to bone health. [1]

Treating Bone Metastases

One of the primary uses of Xgeva is to prevent skeletal fractures and bone loss in patients with cancer that has spread to the bone (metastatic bone disease). [2] This includes cancers such as breast cancer, lung cancer, and prostate cancer. In these cases, Xgeva acts by blocking the activity of a protein called RANKL, which is involved in the formation of osteoclasts, the cells responsible for bone breakdown.

Treating Giant Cell Tumor of Bone

Xgeva is also approved to treat giant cell tumor of bone, a rare condition where a tumor forms on the surface of a bone. [3]

Bone Health in Multiple Myeloma Patients

Additionally, Xgeva is used to treat bone loss in patients with multiple myeloma, a type of blood cancer that affects bone cells. [4]

Bone Density in Postmenopausal Women

Xgeva has also been studied for its potential use in preventing bone fractures in postmenopausal women. [5]

Side Effects and Monitoring

While Xgeva can be effective in managing bone health, it's essential to be aware of potential side effects and monitor bone health closely. According to the manufacturer, Amgen, common side effects of Xgeva include hypocalcemia, nausea, and fatigue. [6]

It's crucial to discuss the potential benefits and risks of Xgeva with a healthcare provider to determine its suitability for a specific condition.

Sources:
[1] DrugPatentWatch.com
[2] Amgen. (2022). XGEVA (denosumab) injection, for intravenous use.
[3] Amgen. (2022). XGEVA prescribing information.
[4] Amgen. (2022). XGEVA for the treatment of multiple myeloma.
[5] Cummings SR, et al. (2009). The effects of denosumab on bone density and risk of fractures. N Engl J Med. 361(2):153-164.
[6] Amgen. (2022). XGEVA Prescribing Information: Side Effects.